Smartphone App for Anxiety and Depression

"The target population for this medical trial are adults aged 40 to 64. There is an abundance of trials available for both younger and older patients, with 396 studies devoted to those under 18 years old and 1729 dedicated to the elderly demographic."

"Affirmative. According to the clinicaltrials.gov website, this ongoing study is presently searching for eligible patients; it was initially posted on September 25th 2023 and recently revised two months later in October 27th 2023. This trial requires 100 participants from a single site."

"Affirmative, the details hosted on clinicaltrials.gov clearly indicate that this research venture is presently recruiting patients. This trial was initiated on September 25th 2023 and its information most recently edited October 27th of the same year. One hundred participants are being sought at a single medical centre for enrolment in this study."

"This research is accepting 100 individuals, aged 40 to 64 with cancer, who also meet the additional qualifications: they must be middle-aged adults, proficient in English and capable of providing informed consent. Additionally, they should showcase a moderate to severe level of anxiety or depression (as evaluated by PHQ-9 and GAD-7) as well as own a mobile phone device."

"The primary evaluation of this trial will be the alteration in anxiety symptoms, as evaluated by Generalized Anxiety Disorder- Q-IV Scale. Secondary goals include studying how diet impacts cancer risk (Self-reported dietary intake used to calculate WCRF/AICR score) and measuring momentary changes in both depression and anxiety symptoms with a modified PHQ/GAD questionnaire on a 101 point scale. This monitoring is set to take place over 12 weeks post baseline."